請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84266
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林琬琬(Wan-Wan Lin) | |
dc.contributor.advisor | 林琬琬(Wan-Wan Lin | wwllaura1119@ntu.edu.tw | ), | |
dc.contributor.author | Chien-Hsieh Chiang | en |
dc.contributor.author | 江建勰 | zh_TW |
dc.date.accessioned | 2023-03-19T22:07:24Z | - |
dc.date.copyright | 2022-07-02 | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-06-21 | |
dc.identifier.citation | Abdullahi, A., and Jeschke, M.G. (2016). White Adipose Tissue Browning: A Double-edged Sword. Trends Endocrinol Metab 27(8), 542-552. doi: 10.1016/j.tem.2016.06.006. Abeysekera, K.W.M., Macpherson, I., Glyn-Owen, K., McPherson, S., Parker, R., Harris, R., et al. (2022). Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review. Lancet Gastroenterol Hepatol. doi: 10.1016/s2468-1253(22)00020-6. Adams, J.M. (2020). Smoking Cessation-Progress, Barriers, and New Opportunities: The Surgeon General's Report on Smoking Cessation. JAMA 323(24), 2470-2471. doi: 10.1001/jama.2020.6647. Aubin, H.J., Farley, A., Lycett, D., Lahmek, P., and Aveyard, P. (2012). Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345, e4439. doi: 10.1136/bmj.e4439. Aveyard, P., and Raw, M. (2012). Improving smoking cessation approaches at the individual level. Tob Control 21(2), 252-257. doi: 10.1136/tobaccocontrol-2011-050348. Bartelt, A., and Heeren, J. (2014). Adipose tissue browning and metabolic health. Nat Rev Endocrinol 10(1), 24-36. doi: 10.1038/nrendo.2013.204. Bartlett, R., Yerbury, J.J., and Sluyter, R. (2013). P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia. Mediators Inflamm 2013, 271813. doi: 10.1155/2013/271813. Beaucage, K.L., Xiao, A., Pollmann, S.I., Grol, M.W., Beach, R.J., Holdsworth, D.W., et al. (2014). Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal 10(2), 291-304. doi: 10.1007/s11302-013-9388-x. Benowitz, N.L., Pipe, A., West, R., Hays, J.T., Tonstad, S., McRae, T., et al. (2018). Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. JAMA Intern Med 178(5), 622-631. doi: 10.1001/jamainternmed.2018.0397. Bergman, B.C., Perreault, L., Hunerdosse, D., Kerege, A., Playdon, M., Samek, A.M., et al. (2012). Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes 61(12), 3156-3166. doi: 10.2337/db12-0418. Blasetti Fantauzzi, C., Menini, S., Iacobini, C., Rossi, C., Santini, E., Solini, A., et al. (2017). Deficiency of the Purinergic Receptor 2X(7) Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome. Oxid Med Cell Longev 2017, 8962458. doi: 10.1155/2017/8962458. Burnstock, G. (2006). Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27(3), 166-176. doi: 10.1016/j.tips.2006.01.005. Bush, T., Lovejoy, J.C., Deprey, M., and Carpenter, K.M. (2016). The effect of tobacco cessation on weight gain, obesity, and diabetes risk. Obesity (Silver Spring) 24(9), 1834-1841. doi: 10.1002/oby.21582. Buzzetti, E., Pinzani, M., and Tsochatzis, E.A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8), 1038-1048. doi: 10.1016/j.metabol.2015.12.012. Campagna, D., Alamo, A., Di Pino, A., Russo, C., Calogero, A.E., Purrello, F., et al. (2019). Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr 11, 85. doi: 10.1186/s13098-019-0482-2. Chen, T.P., Lin, W.Y., Chiang, C.H., Shen, T.H., Huang, K.C., and Yang, K.C. (2021). Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat. J Gastroenterol Hepatol 36(10), 2903-2910. doi: 10.1111/jgh.15544. Chiang, C.H., and Huang, K.C. (2014). Association between metabolic factors and chronic hepatitis B virus infection. World J Gastroenterol 20(23), 7213-7216. doi: 10.3748/wjg.v20.i23.7213. Chiang, C.H., and Huang, K.C. (2020). Diabetes and hepatocellular carcinoma risks in patients with nonalcoholic steatohepatitis related cirrhosis. Hepatobiliary Surg Nutr 9(3), 357-359. doi: 10.21037/hbsn.2019.11.03. Chiang, C.H., Lee, L.T., Hung, S.H., Lin, W.Y., Hung, H.F., Yang, W.S., et al. (2014). Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly. Hepatology 59(6), 2207-2215. doi: 10.1002/hep.27014. Chiang, C.H., Lu, C.W., Han, H.C., Hung, S.H., Lee, Y.H., Yang, K.C., et al. (2016). The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality. Medicine (Baltimore) 95(6), e2699. doi: 10.1097/md.0000000000002699. Chiang, C.H., Yang, H.I., Jen, C.L., Lu, S.N., Wang, L.Y., You, S.L., et al. (2013). Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond) 37(3), 410-415. doi: 10.1038/ijo.2012.63. Chiu, L.Y., Huang, D.Y., and Lin, W.W. (2022). PARP-1 regulates inflammasome activity by poly-ADP-ribosylation of NLRP3 and interaction with TXNIP in primary macrophages. Cell Mol Life Sci 79(2), 108. doi: 10.1007/s00018-022-04138-z. Cloostermans, L., Wendel-Vos, W., Doornbos, G., Howard, B., Craig, C.L., Kivimäki, M., et al. (2015). Independent and combined effects of physical activity and body mass index on the development of Type 2 Diabetes - a meta-analysis of 9 prospective cohort studies. Int J Behav Nutr Phys Act 12, 147. doi: 10.1186/s12966-015-0304-3. Coccurello, R., and Volonté, C. (2020). P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance. Front Endocrinol (Lausanne) 11, 199. doi: 10.3389/fendo.2020.00199. Demine, S., Renard, P., and Arnould, T. (2019). Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases. Cells 8(8). doi: 10.3390/cells8080795. Di Virgilio, F., Dal Ben, D., Sarti, A.C., Giuliani, A.L., and Falzoni, S. (2017). The P2X7 Receptor in Infection and Inflammation. Immunity 47(1), 15-31. doi: 10.1016/j.immuni.2017.06.020. Diehl, A.M., and Day, C. (2017). Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. N Engl J Med 377(21), 2063-2072. doi: 10.1056/NEJMra1503519. Draznin, B., Aroda, V.R., Bakris, G., Benson, G., Brown, F.M., Freeman, R., et al. (2022a). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 45(Supplement_1), S17-s38. doi: 10.2337/dc22-S002. Draznin, B., Aroda, V.R., Bakris, G., Benson, G., Brown, F.M., Freeman, R., et al. (2022b). 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 45(Supplement_1), S39-s45. doi: 10.2337/dc22-S003. Elwyn, G., Frosch, D.L., and Kobrin, S. (2016). Implementing shared decision-making: consider all the consequences. Implement Sci 11, 114. doi: 10.1186/s13012-016-0480-9. Estes, C., Razavi, H., Loomba, R., Younossi, Z., and Sanyal, A.J. (2018). Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1), 123-133. doi: 10.1002/hep.29466. Fabbrizio, P., Amadio, S., Apolloni, S., and Volonté, C. (2017). P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia. Front Cell Neurosci 11, 249. doi: 10.3389/fncel.2017.00249. Farley, A.C., Hajek, P., Lycett, D., and Aveyard, P. (2012). Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 1, Cd006219. doi: 10.1002/14651858.CD006219.pub3. Favero, G., Krajčíková, K., Bonomini, F., Rodella, L.F., Tomečková, V., and Rezzani, R. 2018. Browning of Adipose Tissue and Sirtuin Involvement. Adipose Tissue [Online]. Available: https://www.intechopen.com/chapters/59577 [Accessed November 1, 2021]. Feldman, A.L., Long, G.H., Johansson, I., Weinehall, L., Fhärm, E., Wennberg, P., et al. (2017). Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up. Int J Behav Nutr Phys Act 14(1), 39. doi: 10.1186/s12966-017-0489-8. Gammone, M.A., and D'Orazio, N. (2021). Review: Obesity and COVID-19: A Detrimental Intersection. Front Endocrinol (Lausanne) 12, 652639. doi: 10.3389/fendo.2021.652639. Gao, H., Li, D., Yang, P., Zhao, L., Wei, L., Chen, Y., et al. (2017). Suppression of CD36 attenuates adipogenesis with a reduction of P2X7 expression in 3T3-L1 cells. Biochem Biophys Res Commun 491(1), 204-208. doi: 10.1016/j.bbrc.2017.07.077. Gao, P., Jiang, Y., Wu, H., Sun, F., Li, Y., He, H., et al. (2020). Inhibition of Mitochondrial Calcium Overload by SIRT3 Prevents Obesity- or Age-Related Whitening of Brown Adipose Tissue. Diabetes 69(2), 165-180. doi: 10.2337/db19-0526. García-Ruiz, E., Reynés, B., Díaz-Rúa, R., Ceresi, E., Oliver, P., and Palou, A. (2015). The intake of high-fat diets induces the acquisition of brown adipocyte gene expression features in white adipose tissue. Int J Obes (Lond) 39(11), 1619-1629. doi: 10.1038/ijo.2015.112. Ghaben, A.L., and Scherer, P.E. (2019). Adipogenesis and metabolic health. Nat Rev Mol Cell Biol 20(4), 242-258. doi: 10.1038/s41580-018-0093-z. Giacovazzo, G., Apolloni, S., and Coccurello, R. (2018). Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation. Purinergic Signal 14(3), 299-305. doi: 10.1007/s11302-018-9610-y. Grannell, A., Fallon, F., Al-Najim, W., and le Roux, C. (2021). Obesity and responsibility: Is it time to rethink agency? Obes Rev, e13270. doi: 10.1111/obr.13270. Hills, A.P., Mokhtar, N., and Byrne, N.M. (2014). Assessment of physical activity and energy expenditure: an overview of objective measures. Front Nutr 1, 5. doi: 10.3389/fnut.2014.00005. Hu, Y., Zong, G., Liu, G., Wang, M., Rosner, B., Pan, A., et al. (2018). Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. N Engl J Med 379(7), 623-632. doi: 10.1056/NEJMoa1803626. Idzko, M., Ferrari, D., and Eltzschig, H.K. (2014). Nucleotide signalling during inflammation. Nature 509(7500), 310-317. doi: 10.1038/nature13085. Ikeda, K., and Yamada, T. (2020). UCP1 Dependent and Independent Thermogenesis in Brown and Beige Adipocytes. Front Endocrinol (Lausanne) 11, 498. doi: 10.3389/fendo.2020.00498. Imai, T., Takakuwa, R., Marchand, S., Dentz, E., Bornert, J.M., Messaddeq, N., et al. (2004). Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A 101(13), 4543-4547. doi: 10.1073/pnas.0400356101. Jain, S., and Jacobson, K.A. (2021). Purinergic signaling in diabetes and metabolism. Biochem Pharmacol 187, 114393. doi: 10.1016/j.bcp.2020.114393. Ji, Z., Liu, G.H., and Qu, J. (2021). Mitochondrial sirtuins, metabolism, and aging. J Genet Genomics. doi: 10.1016/j.jgg.2021.11.005. Kim, K., Nam, K.H., Yi, S.A., Park, J.W., Han, J.W., and Lee, J. (2020). Ginsenoside Rg3 Induces Browning of 3T3-L1 Adipocytes by Activating AMPK Signaling. Nutrients 12(2). doi: 10.3390/nu12020427. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6), 393-403. doi: 10.1056/NEJMoa012512. Krist, A.H., Davidson, K.W., Mangione, C.M., Barry, M.J., Cabana, M., Caughey, A.B., et al. (2021). Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA 325(3), 265-279. doi: 10.1001/jama.2020.25019. Lefterova, M.I., Haakonsson, A.K., Lazar, M.A., and Mandrup, S. (2014). PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab 25(6), 293-302. doi: 10.1016/j.tem.2014.04.001. Lin, Y.C., Huang, D.Y., Wang, J.S., Lin, Y.L., Hsieh, S.L., Huang, K.C., et al. (2015). Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization. J Leukoc Biol 97(5), 825-835. doi: 10.1189/jlb.3HI0814-371RR. Ma, Y.C., Zuo, L., Chen, J.H., Luo, Q., Yu, X.Q., Li, Y., et al. (2006). Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10), 2937-2944. doi: 10.1681/asn.2006040368. Maddatu, J., Anderson-Baucum, E., and Evans-Molina, C. (2017). Smoking and the risk of type 2 diabetes. Transl Res 184, 101-107. doi: 10.1016/j.trsl.2017.02.004. Madec, S., Rossi, C., Chiarugi, M., Santini, E., Salvati, A., Ferrannini, E., et al. (2011). Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome? Atherosclerosis 219(2), 552-558. doi: 10.1016/j.atherosclerosis.2011.09.012. Massoud, O., and Charlton, M. (2018). Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clin Liver Dis 22(1), 201-211. doi: 10.1016/j.cld.2017.08.014. Morimoto, A., Ohno, Y., Tatsumi, Y., Nishigaki, Y., Maejima, F., Mizuno, S., et al. (2012). Impact of smoking cessation on incidence of diabetes mellitus among overweight or normal-weight Japanese men. Diabetes Res Clin Pract 96(3), 407-413. doi: 10.1016/j.diabres.2012.03.007. Mota de Sá, P., Richard, A.J., Hang, H., and Stephens, J.M. (2017). Transcriptional Regulation of Adipogenesis. Compr Physiol 7(2), 635-674. doi: 10.1002/cphy.c160022. Ntambi, J.M., and Young-Cheul, K. (2000). Adipocyte differentiation and gene expression. J Nutr 130(12), 3122s-3126s. doi: 10.1093/jn/130.12.3122S. Osborne, B., Bentley, N.L., Montgomery, M.K., and Turner, N. (2016). The role of mitochondrial sirtuins in health and disease. Free Radic Biol Med 100, 164-174. doi: 10.1016/j.freeradbiomed.2016.04.197. Peleg, O., Cohen, A., and Haimov, I. (2020). Depressive symptoms mediate the relationship between sleep disturbances and type 2 diabetes mellitus. J Diabetes 12(4), 305-314. doi: 10.1111/1753-0407.12996. Ponciano-Rodriguez, G., Paez-Martinez, N., Villa-Romero, A., Gutierrez-Grobe, Y., and Mendez-Sanchez, N. (2014). Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation. Metab Syndr Relat Disord 12(4), 242-250. doi: 10.1089/met.2014.0007. Rotondo, J.C., Mazziotta, C., Lanzillotti, C., Stefani, C., Badiale, G., Campione, G., et al. (2022). The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. Cancers (Basel) 14(5). doi: 10.3390/cancers14051116. Savio, L.E.B., de Andrade Mello, P., da Silva, C.G., and Coutinho-Silva, R. (2018). The P2X7 Receptor in Inflammatory Diseases: Angel or Demon? Front Pharmacol 9, 52. doi: 10.3389/fphar.2018.00052. Scheja, L., and Heeren, J. (2019). The endocrine function of adipose tissues in health and cardiometabolic disease. Nat Rev Endocrinol 15(9), 507-524. doi: 10.1038/s41574-019-0230-6. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140(6), 821-832. doi: 10.1016/j.cell.2010.01.040. Sebaa, R., Johnson, J., Pileggi, C., Norgren, M., Xuan, J., Sai, Y., et al. (2019). SIRT3 controls brown fat thermogenesis by deacetylation regulation of pathways upstream of UCP1. Mol Metab 25, 35-49. doi: 10.1016/j.molmet.2019.04.008. Seeland, S., Kettiger, H., Murphy, M., Treiber, A., Giller, J., Kiss, A., et al. (2015). ATP-induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor. Pharmacol Res Perspect 3(2), e00123. doi: 10.1002/prp2.123. Sekar, P., Huang, D.Y., Hsieh, S.L., Chang, S.F., and Lin, W.W. (2018). AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia. Cell Commun Signal 16(1), 83. doi: 10.1186/s12964-018-0293-3. Shintani, A.K., Girard, T.D., Eden, S.K., Arbogast, P.G., Moons, K.G., and Ely, E.W. (2009). Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med 37(11), 2939-2945. doi: 10.1097/CCM.0b013e3181b7fbbb. Shuai, L., Zhang, L.N., Li, B.H., Tang, C.L., Wu, L.Y., Li, J., et al. (2019). SIRT5 Regulates Brown Adipocyte Differentiation and Browning of Subcutaneous White Adipose Tissue. Diabetes 68(7), 1449-1461. doi: 10.2337/db18-1103. Siahpush, M., Singh, G.K., Tibbits, M., Pinard, C.A., Shaikh, R.A., and Yaroch, A. (2014). It is better to be a fat ex-smoker than a thin smoker: findings from the 1997-2004 National Health Interview Survey-National Death Index linkage study. Tob Control 23(5), 395-402. doi: 10.1136/tobaccocontrol-2012-050912. Stadler, M., Tomann, L., Storka, A., Wolzt, M., Peric, S., Bieglmayer, C., et al. (2014). Effects of smoking cessation on beta-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol 170(2), 219-217. doi: 10.1530/eje-13-0590. Stenvers, D.J., Scheer, F., Schrauwen, P., la Fleur, S.E., and Kalsbeek, A. (2019). Circadian clocks and insulin resistance. Nat Rev Endocrinol 15(2), 75-89. doi: 10.1038/s41574-018-0122-1. Student, A.K., Hsu, R.Y., and Lane, M.D. (1980). Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255(10), 4745-4750. Sun, S., Xia, S., Ji, Y., Kersten, S., and Qi, L. (2012). The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61(6), 1471-1478. doi: 10.2337/db11-1389. Tian, J., Venn, A., Otahal, P., and Gall, S. (2015). The association between quitting smoking and weight gain: a systematic review and meta-analysis of prospective cohort studies. Obes Rev 16(10), 883-901. doi: 10.1111/obr.12304. Tian, T., Heine, M., Evangelakos, I., Jaeckstein, M.Y., Schaltenberg, N., Stähler, T., et al. (2020). The P2X7 ion channel is dispensable for energy and metabolic homeostasis of white and brown adipose tissues. Purinergic Signal 16(4), 529-542. doi: 10.1007/s11302-020-09738-7. Tong, X., Chaudhry, Z., Lee, C.C., Bone, R.N., Kanojia, S., Maddatu, J., et al. (2020). Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation. Mol Metab 37, 100975. doi: 10.1016/j.molmet.2020.100975. Tschopp, J., and Schroder, K. (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10(3), 210-215. doi: 10.1038/nri2725. Verkerke, A.R.P., and Kajimura, S. (2021). Oil does more than light the lamp: The multifaceted role of lipids in thermogenic fat. Dev Cell 56(10), 1408-1416. doi: 10.1016/j.devcel.2021.04.018. Vishvanath, L., and Gupta, R.K. (2019). Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest 129(10), 4022-4031. doi: 10.1172/jci129191. Wang, P., Kang, D., Cao, W., Wang, Y., and Liu, Z. (2012). Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 28(2), 109-122. doi: 10.1002/dmrr.1291. Wang, X., and Hai, C. (2015). Redox modulation of adipocyte differentiation: hypothesis of 'Redox Chain' and novel insights into intervention of adipogenesis and obesity. Free Radic Biol Med 89, 99-125. doi: 10.1016/j.freeradbiomed.2015.07.012. World-Health-Organization (2021). Obesity and overweight. [Online]. Available: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight [Accessed May 8, 2022]. Wu, T., Liu, Q., Li, Y., Li, H., Chen, L., Yang, X., et al. (2021). Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway. J Exp Med 218(6). doi: 10.1084/jem.20201203. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12), 1821-1830. doi: 10.1172/jci19451. Yang, J.D., Ahmed, F., Mara, K.C., Addissie, B.D., Allen, A.M., Gores, G.J., et al. (2020). Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology 71(3), 907-916. doi: 10.1002/hep.30858. Yeh, H.C., Duncan, B.B., Schmidt, M.I., Wang, N.Y., and Brancati, F.L. (2010). Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 152(1), 10-17. doi: 10.7326/0003-4819-152-1-201001050-00005. Yeh, W.C., Cao, Z., Classon, M., and McKnight, S.L. (1995). Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9(2), 168-181. doi: 10.1101/gad.9.2.168. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84266 | - |
dc.description.abstract | 近年已知第二型糖尿病會促成肝癌與不良之肝臟預後。要預防糖尿病,維持健康之體位與生活型態乃基本功。然而,戒菸後之體重增加,若未有適當之配套介入措施,反而會在短期內增加第二型糖尿病的風險。除了臨床研究,探索脂肪細胞分化時的調節機制之也是重要的肥胖研究領域。其中,P2X7接受器在脂肪細胞分化期間的角色尚有許多未知。 本論文的第一部份為臨床研究,探討整合戒菸治療及體重控制之介入模式,是否能改善糖尿病前期抽菸者之長期血糖預後。在此醫病共享決策概念分派之非隨機對照試驗,參加介入之糖尿病前期抽菸者接受FIT2模式,為同時整合完整16周之戒菸治療服務,及戒菸後體重控制之營養與運動指導;對照組之糖尿病前期抽菸者僅接受一般照護。本計畫在2013年至2017年建立之前瞻性糖尿病前期抽菸者世代,收納共589位民眾,279位民眾加入介入組。歷經平均1316天的追蹤後,217名(36.8%)發生第二型糖尿病,68名(11.5%)恢復至正常血糖。589位受試者皆進行意向分析,發現FIT2模式介入組相較於一般照護組,有較低的第二型糖尿病發生風險(HR:0.58;95% CI:0.40–0.84),與較高的機會恢復至正常血糖(HR:1.91;95% CI:1.04–3.53)。依據532名受試者於六個月時實際戒菸成果進行之時間變動分析,仍發現參與FIT2模式之成功戒菸者相較於對照組,保有較低的第二型糖尿病發生風險(HR:0.63;95% CI:0.44–0.92),與較高恢復至正常血糖的機會(HR:1.83;95% CI:1.01–3.30)。 本論文的第二部份為基礎研究,探討P2X7接受器在脂肪細胞分化期間的調控角色。本研究是採用體外3T3-L1脂肪細胞株傳統的體外兩階段分化模式。實驗過程分別使用P2X7促進劑BzATP與P2X7抑制劑A438079來了解P2X7之功能。結果發現在脂肪細胞分化第1天至第4天,P2X7的蛋白質量與細胞內脂質堆積皆逐漸增加。在分化過程第0天與第2天加入BzATP會增加脂質堆積量,反之在同樣時間點加入A438079會減少脂質堆積量。PPARγ與C/EBPα的蛋白質量在脂肪細胞分化第4天皆增加,但在分化第0天與第2天不管是加BzATP或A438079,都不會影響PPARγ與C/EBPα之基因表現。同時,BzATP也會增加分化第4天時細胞內之三酸甘油酯含量與細胞外之甘油分泌量,A438079則會減少細胞內之三酸甘油酯含量與細胞外之甘油分泌量。當只在脂肪細胞分化的第二階段加藥時,BzATP仍會增加分化第4天細胞內之脂質堆積及三酸甘油酯含量,與細胞外之甘油之分泌量;一致地,在此過程BzATP不會改變PPARγ與C/EBPα原本在分化第4天增加的基因表現量。然而,若在脂肪細胞分化的第4天才加BzATP或A438079,皆不影響已分化脂肪細胞第7天之細胞內三酸甘油酯含量與細胞外甘油之分泌量。值得注意的是,在脂肪細胞分化的第二階段投以BzATP,會抑制分化第4天時與脂肪棕化反應相關PRDM16、PGC-1α與UCP-1的基因表現量,而此抑制隨BzATP劑量加大而更明顯。此外,在分化第0天與第2天加BzATP會抑制sirtuin-3與sirtuin-5在分化第4天的基因表現量。僅在脂肪細胞分化的第二階段投以BzATP,也同樣會抑制sirtuin-3與sirtuin-5被胰島素誘導後上升的mRNA量。 綜上所述,本論文之臨床研究發現FIT2模式介入組相較於一般照護組,長期追蹤後的第二型糖尿病發生風險較低。本團隊建議應整合戒菸治療與戒菸後體重控制之營養與運動指導,以預防第二型糖尿病之發生。本論文在脂肪細胞的研究進一步發現,P2X7接受器活化後會藉由抑制sirtuin-3、sirtuin-5與棕色脂肪基因在脂肪細胞分化過程的表現量,而促進脂質堆積。本論文的系列成果將對臨床與基礎肥胖研究帶來更多啟發。 | zh_TW |
dc.description.abstract | Type 2 diabetes (T2D) contributes to liver cancer and poor liver outcomes. Maintaining a healthy weight and lifestyle is the cornerstone of diabetes prevention. Post-cessation weight gain (PCWG) facilitates short-term T2D risk in prediabetic smokers in the absence of complementary measures. Stepping into regulatory mechanisms involved in adipocyte differentiation is also imperative in obesity research. Little has investigated the role of the P2X7 receptor during adipogenesis. In the first part of this dissertation, we aimed to investigate whether long-term glycemic outcomes would be improved by an organized program fighting both smoking and PCWG in prediabetic smokers. In this shared decision-making-based non-randomized controlled trial, prediabetic smokers joined the Fight Tobacco and Stay Fit (FIT2) program or received usual care. The 16-week FIT2 program combined smoking cessation therapy with individualized coaching in diet and physical activity strategies for PCWG restriction. During a mean follow-up period of 1316 days, 217 participants (36.8%) developed T2D, and 68 (11.5%) regressed to normoglycemia. In the intention-to-treat analysis (n = 589), the FIT2 program was associated with a reduced T2D risk (HR, 0.58; 95% CI, 0.40–0.84) and a higher probability of regression to normoglycemia (HR, 1.91; 95% CI, 1.04–3.53) compared with usual care. The post-program quitters were at lower T2D risk (HR, 0.63; 95% CI, 0.44–0.92) and were more likely to regress to normoglycemia (HR, 1.83; 95% CI, 1.01–3.30) compared with the controls in the time-varying analysis (n = 532). In the second part of this dissertation, we sought to explore the regulatory roles of P2X7 in adipocytes. This study utilized the in vitro 3T3-L1 differentiation model under the treatment with two-stage differentiation agents. Lipid accumulation, intracellular triglyceride, and extracellular glycerol were determined. The selective P2X7 agonist BzATP and antagonist A438079 were administered to investigate the functions of P2X7. We found that the expression of P2X7 and the lipid accumulation increased during adipocyte differentiation from D0 to D4. When administered at D0/D2, BzATP enhanced, while A438079 attenuated the degree of lipid accumulation during adipocyte differentiation. Neither did BzATP and A438079 administration affect the expression of PPARγ and C/EBPα genes that increased at D4. In addition, both intracellular triglyceride and extracellular glycerol levels at D4 were enhanced by BzATP administration and reduced by A438079 treatment. When administered at stage 2 of adipocyte differentiation, BzATP consistently enhanced lipid accumulation and intracellular triglyceride and extracellular glycerol levels without affecting mRNA and protein levels of PPARγ and C/EBPα that increased at D4. However, treating BzATP or A438079 at D4 did not affect intracellular triglyceride formation and extracellular glycerol release in differentiated adipocytes at D7. Notably, BzATP administration at stage 2 exerted a concentration-dependent inhibition on the enhanced expression of browning associated PRDM16, PGC-1α, and UCP-1 genes at D4. Furthermore, BzATP administration at D0/D2 inhibited the protein and mRNA levels of sirtuin-3/5 at D4. BzATP treatment at stage 2 also suppressed the mRNA levels of sirtuin-3/5 genes upregulated by insulin. In conclusion, our clinical study indicated that the FIT2 program was negatively associated with long-term T2D risk compared with usual care. To prevent T2D development, we recommend simultaneously promoting smoking abstinence and lifestyle coaching for PCWG restriction. In addition, our in vitro study in adipocytes demonstrated that P2X7 enhances lipid accumulation during adipogenesis by suppressing the expression of sirtuin-3/5 and the browning genes. Our serial findings will spark more advanced clinical and basic obesity research. | en |
dc.description.provenance | Made available in DSpace on 2023-03-19T22:07:24Z (GMT). No. of bitstreams: 1 U0001-2106202202070700.pdf: 2530016 bytes, checksum: 1321a8e731bff616c54d09cfc72f00b9 (MD5) Previous issue date: 2022 | en |
dc.description.tableofcontents | 口試委員會審定書 I 謝辭 II 中文摘要 III ABSTRACT V CONTENTS VIII LIST OF FIGURES & TABLES IX LIST OF ABBREVIATIONS XI CHAPTER 1 Introduction 1 1.1 Linking Liver Cancer to Type 2 Diabetes 1 1.2 Addressing Obesity and Smoking to Prevent Type 2 Diabetes 2 1.3 Adipogenesis and Browning in Obesity 3 1.4 Cellular Function and Pathological Role of P2X7 in Inflammation-Related Diseases 5 1.5 Undetermined P2X7 Roles in Adipocytes Differentiation 6 CHAPTER 2 Specific Aims 8 2.1 Non-Randomized Controlled Trial 8 2.2 Pharmacological Research 8 CHAPTER 3 Methods 9 3.1 Non-Randomized Controlled Trial 9 3.2 Pharmacological Research 16 CHAPTER 4 Results 20 4.1 Non-Randomized Controlled Trial 20 4.2 Pharmacological Research 23 CHAPTER 5 Discussion 28 5.1 Non-Randomized Controlled Trial 28 5.2 Pharmacological Research 32 REFERENCES 36 APPENDICES 68 | |
dc.language.iso | en | |
dc.title | 從限制戒菸後肥胖以預防糖尿病至探討P2X7在脂肪細胞分化過程的角色 | zh_TW |
dc.title | From Incorporating Post-Cessation Obesity Control in Diabetes Prevention to Exploring the Roles of P2X7 During Adipogenesis | en |
dc.type | Thesis | |
dc.date.schoolyear | 110-2 | |
dc.description.degree | 博士 | |
dc.contributor.author-orcid | 0000-0003-0894-4498 | |
dc.contributor.oralexamcommittee | 林泰元(Thai-Yen Ling),蔡丰喬(Feng-Chiao Tsai),陳玉怜(Yuh-Lien Chen),黃國晉(Kuo-Chin Huang) | |
dc.subject.keyword | 脂肪細胞分化,棕化,第二型糖尿病,肥胖症,P2X7接受器,戒菸後之體重增加, | zh_TW |
dc.subject.keyword | adipogenesis,browning,type 2 diabetes mellitus,obesity,P2X7,post-cessation weight gain, | en |
dc.relation.page | 74 | |
dc.identifier.doi | 10.6342/NTU202201032 | |
dc.rights.note | 同意授權(限校園內公開) | |
dc.date.accepted | 2022-06-22 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
dc.date.embargo-lift | 2022-07-02 | - |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2106202202070700.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 2.47 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。